Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Ryan McTaggart

Vascular & Interventional Radiology Roanoke, VA Medical Doctor

NPI 1164640389 CMS profile 453620

1906 Belleview Ave Se, Roanoke, VA 24014

Open in the dashboard

General payments

$102,551

133 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$286,760 paid to institutions, not to them · program years 2020–2025

Through program year 2023, Ryan McTaggart of Roanoke, VA is reported in the CMS Open Payments database as having received $102,551 across 133 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $286,760 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $112 1
2022 General $187 2
2021 General $416 4
2020 General $8,882 13
2019 General $92,954 113

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan McTaggart
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Ryan McTaggart were reported at $0. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Ryan McTaggart Vascular & Interventional Radiology median Middle half National median
2019 $92,954 $422 $125–$1,555 $163
2020 $8,882 $200 $68–$652 $114
2021 $416 $280 $99–$866 $132
2022 $187 $433 $137–$1,497 $149
2023 $112 $506 $152–$2,019 $160
2024 $0 $556 $175–$1,930 $164
2025 $0 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Stryker Corporation $88,742 101 payments
  2. Siemens Medical Solutions USA, Inc. $11,953 20 payments
  3. MicroVention, Inc. $1,416 6 payments
  4. Rapid Medical LTD $154 1 payment
  5. Medtronic USA, Inc. $138 2 payments
  6. Balt USA, LLC $117 2 payments
  7. Biedermann Motech, Inc. $30 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $72,888 11 payments
  2. Travel and Lodging $24,084 67 payments
  3. Food and Beverage $3,092 54 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,487 1 payment
Products named General payments · program years 2019–2023
  1. TREVO $80,526 75 payments
  2. CATALYST $11,250 9 payments
  3. FLOWGATE $9,330 4 payments
  4. Artis icono $8,855 12 payments
  5. NEURO $5,632 17 payments
  6. WEB $1,416 6 payments
  7. SURPASS $472 2 payments
  8. ARTIS icono biplane $337 4 payments
  9. Artis icono floor $175 1 payment
  10. Comaneci $154 1 payment
  11. Other $520 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 129 billing codes

Paid by Medicare

$103,334

Of which drugs: $700

Medicare patients

2,007

Average age 76

Services billed

8,944

1,176 women, 831 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 35%
Depression 32%
Chronic kidney disease 30%
Diabetes 29%
Atrial fibrillation 23%
Heart failure 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoterate meglumine, 0.1 ml A9575 Office 31 5,300 $533

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record